Tamara van Donge

Personalized use of ibuprofen in preterm neonates 111 6 17. Hoftiezer L, Hukkelhoven CW, Hogeveen M, Straatman HM, van Lingen RA. Defining small- for-gestational-age: prescriptive versus descriptive birthweight standards. Eur J Pediatr. 2016;175(8):1047-57. 18. Engbers AGJ, Flint RB, Voller S, de Klerk JCA, Reiss IKM, Andriessen P, et al. Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus. Br J Clin Pharmacol. 2020;86(10):2028-39. 19. Gregoire N, Desfrere L, Roze JC, Kibleur Y, Koehne P. Population pharmacokinetic analysis of Ibuprofen enantiomers in preterm newborn infants. J Clin Pharmacol. 2008;48(12):1460-8. 20. Gal P, Ransom JL, Schall S, Weaver RL, Bird A, Brown Y. Indomethacin for patent ductus arteriosus closure. Application of serum concentrations and pharmacodynamics to improve response. J Perinatol . 1990;10(1):20-26.